RHONDA KELLY: Open Payments
NPI 1326697566 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 22 payments from 10 companies in 2025. Trend: 2023 $591 · 2024 $571 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $137 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
Products named: QULIPTA, FANAPT, REXULTI, UBRELVY, MOUNJARO, NURTEC ODT, CAPLYTA, REPATHA.
Industry payments across KY — which companies pay providers there.
